☰

Marco d. DiBonaventura, Ph.D. - Publications

Affiliations: 
2007 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Social Psychology
Tree Info Grants Similar researchers PubMed Report error

5/277 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Vietri J, DiBonaventura Md, Chilson E, Malhotra D, Emir B. Sa1010 – Lack of Recommended Pneumococcal Conjugate Vaccine Uptake Among Gastroenterology Patients At High Risk Gastroenterology. 156: S-253. DOI: 10.1016/S0016-5085(19)37437-2  0.521
2012 Gupta S, Vietri J, DiBonaventura M. PCV86 The Burden of Non-Adherent Prescription Cost Cutting Among Diagnosed Hypertension Patients in Russia Value in Health. 15: A377. DOI: 10.1016/J.Jval.2012.08.1029  0.507
2008 Dibonaventura Md, Chapman GB. Do decision biases predict bad decisions? Omission bias, naturalness bias, and influenza vaccination. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 532-9. PMID 18319507 DOI: 10.1177/0272989X07312723  0.441
2008 DiBonaventura Md, Chapman GB. The effect of barrier underestimation on weight management and exercise change. Psychology, Health & Medicine. 13: 111-22. PMID 18066924 DOI: 10.1080/13548500701426711  0.46
2006 Capolongo MJ, Dibonaventura Md, Chapman GB. Physician vaccinate thyself: why influenza vaccination rates are higher among clinicians than among nonclinicians. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 31: 288-96. PMID 16700643 DOI: 10.1207/S15324796Abm3103_11  0.505
Low-probability matches (unlikely to be authored by this person)
2008 Mora PA, DiBonaventura MD, Idler E, Leventhal EA, Leventhal H. Psychological factors influencing self-assessments of health: toward an understanding of the mechanisms underlying how people rate their own health. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 36: 292-303. PMID 18937021 DOI: 10.1007/S12160-008-9065-4  0.291
2013 Mora PA, Orsak G, DiBonaventura MD, Leventhal EA. Why do comparative assessments predict health? The role of self-assessed health in the formation of comparative health judgments. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 32: 1175-8. PMID 23527516 DOI: 10.1037/A0032044  0.281
2012 Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. Plos One. 7: e50553. PMID 23226312 DOI: 10.1371/journal.pone.0050553  0.269
2012 Mora PA, Beamon T, Preuitt L, DiBonaventura M, Leventhal EA, Leventhal H. Heterogeneity in depression symptoms and health status among older adults. Journal of Aging and Health. 24: 879-96. PMID 22491993 DOI: 10.1177/0898264312440323  0.266
2010 DiBonaventura M, Goren A, Gupta S, Wagner J, Freedman D. PIN61 INFLUENZA RISK AND VACCINATION RATES IN EUROPE: A NATIONWIDE SURVEY OF ADULTS Value in Health. 13: A250. DOI: 10.1016/S1098-3015(11)71896-4  0.243
2014 Kumar M, Fukuda T, Stankus AP, DiBonaventura M. Influenza Vaccination In Japan Among The General Population And High-Risk Groups. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A804. PMID 27203027 DOI: 10.1016/j.jval.2014.08.509  0.232
2012 DiBonaventura Md, Andrews LM, Yadao AM, Kahler KH. The effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 821-9. PMID 23252362 DOI: 10.1586/erp.12.60  0.23
2009 Howell EA, Mora PA, DiBonaventura MD, Leventhal H. Modifiable factors associated with changes in postpartum depressive symptoms. Archives of Women's Mental Health. 12: 113-20. PMID 19238520 DOI: 10.1007/S00737-009-0056-7  0.227
2011 DiBonaventura M, Wagner J, Goren A. PIN41 INFLUENZA VACCINATION RATES AMONG HIGH RISK GROUPS IN THE UNITED STATES Value in Health. 14: A121. DOI: 10.1016/j.jval.2011.02.672  0.225
2014 DiBonaventura M, Kumar M. The Association Of Adherence And Health Behaviors With Health Status Among Patients With Hypertension In Japan Value in Health. 17: A120. DOI: 10.1016/j.jval.2014.03.698  0.223
2014 Kumar M, Gupta S, Liu G, Stankus AP, DiBonaventura M. Influenza Vaccination in China Among the Urban Population and High-Risk Groups. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A804. PMID 27203031 DOI: 10.1016/j.jval.2014.08.511  0.219
2015 DiBonaventura M, Richard L, Kumar M, Forsythe A, Flores NM, Moline M. The Association between Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Healthcare Resource Use. Plos One. 10: e0137117. PMID 26426805 DOI: 10.1371/journal.pone.0137117  0.217
2012 LaMori JC, Mody SH, Gross HJ, DiBonaventura Md, Patel A, Schein J, Nelson WW. Dyspepsia and disease burden among patients with atrial fibrillation. Critical Pathways in Cardiology. 11: 14-9. PMID 22337216 DOI: 10.1097/HPC.0b013e318246fae8  0.208
2012 Kalsekar I, Wagner JS, DiBonaventura M, Bates J, Forbes R, Hebden T. Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. Health and Quality of Life Outcomes. 10: 81. PMID 22805425 DOI: 10.1186/1477-7525-10-81  0.202
2014 DiBonaventura M, Kumar M. The association of adherence and health behaviors with health status among patients with type 2 diabetes in Japan Value in Health. 17: A255. DOI: 10.1016/J.JVAL.2014.03.1485  0.201
2019 Dignass A, Waller J, Cappelleri JC, Modesto I, Kisser A, Dietz L, DiBonaventura M, Wood R, May M, Libutzki B, Bargo D. Living with ulcerative colitis in Germany: A retrospective analysis of dose escalation, concomitant treatment use and healthcare costs. Journal of Medical Economics. 1. PMID 31858853 DOI: 10.1080/13696998.2019.1707210  0.194
2012 Vanderpoel J, Lofland J, Schenkel B, Dibonaventura M, Gross H. PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel Disease Value in Health. 15: A102-A103. DOI: 10.1016/J.Jval.2012.03.558  0.191
2020 Girolomoni G, Luger T, Nosbaum A, Gruben D, Romero W, Llamado LJ, DiBonaventura M. The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey. Dermatology and Therapy. PMID 33180320 DOI: 10.1007/s13555-020-00459-8  0.189
2015 Mishima K, DiBonaventura Md, Gross H. The burden of insomnia in Japan. Nature and Science of Sleep. 7: 1-11. PMID 25610008 DOI: 10.2147/NSS.S73437  0.189
2012 Dibonaventura M, Andrews L, Sternbach N, Yadao A, Kahler K. PMS44 Impact of Gout on Productivity and Health-Related Quality of Life Outcomes Among Patients with Hypertension in the National Health and Wellness Survey Value in Health. 15: A41. DOI: 10.1016/j.jval.2012.03.233  0.188
2012 Dibonaventura M, Fukuda T, Stankus A. PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan: The Japan National Health and Wellness Survey Value in Health. 15: A646-A647. DOI: 10.1016/J.JVAL.2012.08.262  0.187
2011 DiBonaventura M, Gupta S, McDonald M, Sadosky A, Pettitt D, Silverman S. 273 PATIENT-RATED OSTEOARTHRITIS SEVERITY IN AN EMPLOYED POPULATION: COMPARISON OF IMPACT WITH NON-OSTEOARTHRITIS WORKERS USING DATA FROM THE NATIONAL HEALTH AND WELLNESS SURVEY Osteoarthritis and Cartilage. 19: S130. DOI: 10.1016/S1063-4584(11)60300-2  0.187
2011 Dibonaventura M, Pisa G, Schwankl M. PSY39 Predictors of Health Utilities Among Patients with Rheumatoid Arthritis in Europe Value in Health. 14: A417. DOI: 10.1016/j.jval.2011.08.1011  0.186
2014 Lamori J, Gross HJ, Dibonaventura M, Bookhart BK, Schein J. Prior myocardial infarction and presence of upper gastrointestinal conditions among patients with venous thromboembolism: Prevalence, associated comorbidities and burden Journal of Clinical Pharmacy and Therapeutics. 39: 253-258. PMID 24494931 DOI: 10.1111/jcpt.12133  0.184
2014 DiBonaventura MD, Copher R, Basurto E, Faria C, Lorenzo R. Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer American Health and Drug Benefits. 7: 386-396.  0.183
2019 Boeri M, Myers K, Ervin C, Marren A, DiBonaventura M, Cappelleri JC, Hauber B, Rubin DT. Patient and physician preferences for ulcerative colitis treatments in the United States. Clinical and Experimental Gastroenterology. 12: 263-278. PMID 31354328 DOI: 10.2147/Ceg.S206970  0.179
2019 Yamabe K, DiBonaventura MD, Pashos CL. Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries. Clinicoeconomics and Outcomes Research : Ceor. 11: 61-71. PMID 30662276 DOI: 10.2147/CEOR.S179903  0.175
2017 Ding B, DiBonaventura M, Karlsson N, Bergström G, Holmgren U. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey. International Journal of Chronic Obstructive Pulmonary Disease. 12: 529-539. PMID 28223793 DOI: 10.2147/COPD.S114085  0.175
2021 Bargo D, Tritton T, Cappelleri JC, DiBonaventura M, Smith TW, Tsuchiya T, Gardiner S, Modesto I, Holbrook T, Bluff D, Kobayashi T. Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use. Inflammatory Intestinal Diseases. 6: 186-198. PMID 35083284 DOI: 10.1159/000519123  0.172
2013 Pomerantz D, Machado M, DiBonaventura M. The Impact Of Private Versus Public Insurance On Health Status, Work Productivity And Health Care Utilization For Individuals Residing In Brazil Value in Health. 16: A76. DOI: 10.1016/j.jval.2013.03.342  0.171
2011 Sadosky A, DiBonaventura M, Gupta S, McDonald M. Osteoarthritis pain in the workforce: evaluating its impact on health status, productivity, and health care costs The Journal of Pain. 12: P29. DOI: 10.1016/J.JPAIN.2011.02.118  0.169
2018 DiBonaventura MD, Meincke H, Le Lay A, Fournier J, Bakker E, Ehrenreich A. Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 11: 1-10. PMID 29317841 DOI: 10.2147/DMSO.S129247  0.169
2014 Parasuraman S, DiBonaventura M, Reith K, Concialdi K. Treatment Patterns and Hydroxyurea Response Among Patients with Polycythemia Vera Blood. 124: 1852-1852. DOI: 10.1182/blood.v124.21.1852.1852  0.168
2021 Kwatra SG, Gruben D, Fung S, DiBonaventura M. Psychosocial Comorbidities and Health Status Among Adults with Moderate-to-Severe Atopic Dermatitis: A 2017 US National Health and Wellness Survey Analysis. Advances in Therapy. 38: 1627-1637. PMID 33555555 DOI: 10.1007/s12325-021-01630-z  0.168
2018 Yarlas A, Rubin DT, Panés J, Lindsay JO, Vermeire S, Bayliss M, Cappelleri JC, Maher S, Bushmakin AG, Chen LA, DiBonaventura M. Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey. Journal of Crohn's & Colitis. 12: 600-609. PMID 29718244 DOI: 10.1093/ecco-jcc/jjy024  0.167
2010 Goren A, Gupta S, DiBonaventura M, Freedman D. PSY50 HEALTH-RELATED QUALITY OF LIFE, HEALTH UTILITIES, AND WORK PRODUCTIVITY ASSOCIATED WITH SPECIFIC OBESITY-RELATED COMORBIDITIES Value in Health. 13: A469. DOI: 10.1016/S1098-3015(11)72999-0  0.166
2011 Williams SA, Pollack MF, Dibonaventura M. Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 91: 363-70. PMID 21251725 DOI: 10.1016/j.diabres.2010.12.027  0.166
2014 DiBonaventura M, Richard L, Kumar M, Forsythe A, Moline M, Flores N. The Effect of Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Health Care Resource Use. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A401. PMID 27200956 DOI: 10.1016/j.jval.2014.08.917  0.165
2012 Allen-Ramey FC, Gupta S, DiBonaventura MD. Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes. International Journal of Chronic Obstructive Pulmonary Disease. 7: 779-87. PMID 23226014 DOI: 10.2147/COPD.S35501  0.164
2012 DiBonaventura M, Gross H, Wagner J. PIN46 The Effect of Anemia on Health Status and Work Productivity Among Treated Hepatitis C Patients Value in Health. 15: A245. DOI: 10.1016/j.jval.2012.03.1322  0.164
2014 Moline M, DiBonaventura Md, Shah D, Ben-Joseph R. Impact of middle-of-the-night awakenings on health status, activity impairment, and costs. Nature and Science of Sleep. 6: 101-11. PMID 25093001 DOI: 10.2147/NSS.S66696  0.163
2014 DiBonaventura M, Wintfeld N, Huang J, Goren A. The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs. Patient Preference and Adherence. 8: 873-82. PMID 24971002 DOI: 10.2147/PPA.S55550  0.162
2021 Silverberg JI, Thyssen JP, Simpson EL, Yosipovitch G, Ständer S, Valdez H, Rojo R, Biswas P, Myers DE, Feeney C, DiBonaventura M. Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes. American Journal of Clinical Dermatology. PMID 33954933 DOI: 10.1007/s40257-021-00604-9  0.161
2016 Lee LK, Ebata N, Hlavacek P, DiBonaventura M, Cappelleri JC, Sadosky A. Humanistic and economic burden of fibromyalgia in Japan. Journal of Pain Research. 9: 967-978. PMID 27853390 DOI: 10.2147/JPR.S110707  0.161
2009 Krishnarajah G, DiBonaventura M, Wagner S, Gupta S. PDB38 THE EFFECT OF WEIGHT CHANGES ON HEALTH-RELATED QUALITY OF LIFE AND WORK IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES Value in Health. 12: A104. DOI: 10.1016/S1098-3015(10)73581-6  0.16
2011 Sun SX, Dibonaventura M, Purayidathil FW, Wagner JS, Dabbous O, Mody R. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Digestive Diseases and Sciences. 56: 2688-95. PMID 21380761 DOI: 10.1007/s10620-011-1639-5  0.159
2011 Rendas-Baum R, Smith K, DiBonaventura M, Bayliss M, Alonso J, Ferrer M, Vilagut G. PIH44 Health-Related Quality of Life for Patients with Chronic Conditions: Revealing the Profile of Burden Associated with Co-Morbid Physical and Mental Conditions in Respondents from Five European Countries Value in Health. 14: A405. DOI: 10.1016/j.jval.2011.08.947  0.159
2011 DiBonaventura MD, Cappelleri JC, Joshi AV. Association between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patients. Pain Medicine (Malden, Mass.). 12: 799-807. PMID 21481171 DOI: 10.1111/j.1526-4637.2011.01103.x  0.158
2011 Marrett E, Dibonaventura M, Zhang Q. PCV111 Economic Burden and Health- Related Quality of Life in European Patients with Peripheral Arterial Disease Value in Health. 14: A384. DOI: 10.1016/J.JVAL.2011.08.831  0.157
2012 Orlic Z, Dibonaventura M, Gupta S, Pomerantz D, Isherwood G. PDB73 Health Outcomes Among Type 2 Diabetes Patients With Comorbid Obesity in Brazil Value in Health. 15: A184. DOI: 10.1016/j.jval.2012.03.994  0.157
2015 Sadosky AB, DiBonaventura M, Cappelleri JC, Ebata N, Fujii K. The association between lower back pain and health status, work productivity, and health care resource use in Japan. Journal of Pain Research. 8: 119-30. PMID 25750546 DOI: 10.2147/JPR.S76649  0.156
2012 Annunziata K, Pomerantz D, Dibonaventura M, Follador W. PDB71 Patient Access, Hba1C Knowledge, and Health Outcomes Among Type 2 Diabetes Patients in Brazil Value in Health. 15: A506. DOI: 10.1016/j.jval.2012.08.1714  0.156
2020 Brookes MJ, Waller J, Cappelleri JC, Modesto I, DiBonaventura MD, Bohm N, Mokgokong R, Massey O, Wood R, Bargo D. Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis. Bmj Open Gastroenterology. 7. PMID 32938582 DOI: 10.1136/bmjgast-2020-000456  0.155
2012 Goren A, Gupta S, Dibonaventura M. PIH32 Demographic and Health Characteristics Associated with Intentional and Unintentional Non-Adherence among Costly Chronic Conditions in the United States Value in Health. 15: A197. DOI: 10.1016/J.JVAL.2012.03.1064  0.155
2012 DiBonaventura Md, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H. The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. Copd. 9: 46-57. PMID 22292597 DOI: 10.3109/15412555.2011.634863  0.155
2012 DiBonaventura M, Liu G, Stankus A. PRS8 The Effect of Asthma on Health Status, Work Productivity, and Health Care Resource Use in Urban China Value in Health. 15: A641. DOI: 10.1016/j.jval.2012.08.229  0.155
2013 de Renteria J, DiBonaventura M, Suponcic S, Pomerantz D. Societal Unmet Needs in Brazil: Examining Prevalence, Treatment Rates, and Health Outcomes Value in Health. 16: A676. DOI: 10.1016/j.jval.2013.08.1977  0.154
2011 DiBonaventura M, Sun SX, Bolge SC, Wagner JS, Mody R. Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Current Medical Research and Opinion. 27: 2213-22. PMID 21951105 DOI: 10.1185/03007995.2011.623157  0.154
2012 Dibonaventura MD, Gupta S, McDonald M, Sadosky A, Pettitt D, Silverman S. Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health and Quality of Life Outcomes. 10: 30. PMID 22420468 DOI: 10.1186/1477-7525-10-30  0.153
2012 DiBonaventura M, Fukuda T, Stankus A. PR4 The Effect of Neuropathic Pain on Health Status, Work Productivity Loss, and Health Care Resource Use in Japan Value in Health. 15: A609. DOI: 10.1016/J.JVAL.2012.08.051  0.153
2014 Pignot M, DiBonaventura M. The Relationship Between Macular Edema and Health Outcomes Among Patients With Diabetes in Western Europe. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A353-4. PMID 27200694 DOI: 10.1016/j.jval.2014.08.745  0.15
2023 Dubinsky MC, Armuzzi A, Gecse KB, Ullman T, Bushmakin AG, DiBonaventura M, Cappelleri JC, Connelly SB, Woolcott JC, Salese L. Improvements in disease activity partially mediate the effect of tofacitinib treatment on generic and disease-specific health-related quality of life in patients with ulcerative colitis: data from the OCTAVE program. Digestive Diseases (Basel, Switzerland). PMID 36603566 DOI: 10.1159/000528788  0.15
2013 Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause (New York, N.Y.). 20: 518-24. PMID 23403500 DOI: 10.1097/GME.0b013e31827d38a5  0.149
2018 Yarlas A, Maher SM, Bayliss MS, Lovley A, Cappelleri JC, DiBonaventura MD. Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review. Journal of Patient-Reported Outcomes. 2: 62. PMID 30547275 DOI: 10.1186/s41687-018-0088-8  0.148
2014 Annunziata K, DiBonaventura M, Sternbach N. Patient awareness of HbA1c in type 2 diabetes: trends and implications for health outcomes Value in Health. 17: A263. DOI: 10.1016/j.jval.2014.03.1532  0.147
2019 Milev S, DiBonaventura MD, Quon P, Goh JW, Bourret J, Peeples-Lamirande K, Soonasra A, Cappelleri JC, Quirk D. An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States. Journal of Medical Economics. 1. PMID 31012362 DOI: 10.1080/13696998.2019.1609481  0.147
2017 DiBonaventura MD, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri JC, Hlavacek P, Alexander AH, Stacey BR, Markman JD, Farrar JT. The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey. Journal of Pain Research. 10: 2525-2538. PMID 29138590 DOI: 10.2147/Jpr.S127014  0.147
2012 Dibonaventura MD, Prior M, Prieto P, Fortea J. Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom. Clinical and Experimental Gastroenterology. 5: 203-12. PMID 23162373 DOI: 10.2147/CEG.S35568  0.146
2013 Pignot M, DiBonaventura M. Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients: Comparison with Matched Controls Value in Health. 16: A569-A570. DOI: 10.1016/J.JVAL.2013.08.1527  0.144
2011 Dibonaventura Md, Gupta S, McDonald M, Sadosky A. Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey. Bmc Musculoskeletal Disorders. 12: 83. PMID 21527024 DOI: 10.1186/1471-2474-12-83  0.143
2011 Naim A, DiBonaventura M, Lofland J, Freedman D. PSY25 RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE Value in Health. 14: A63. DOI: 10.1016/J.Jval.2011.02.358  0.141
2009 Hay J, Coups EJ, Ford J, DiBonaventura M. Exposure to mass media health information, skin cancer beliefs, and sun protection behaviors in a United States probability sample. Journal of the American Academy of Dermatology. 61: 783-92. PMID 19596487 DOI: 10.1016/J.Jaad.2009.04.023  0.14
2017 Wong WB, Ravelo A, DiBonaventura M, Shah-Manek B. Oncologists’ perceptions of affordability in the NCCN evidence block value frameworks. Journal of Clinical Oncology. 35: 6511-6511. DOI: 10.1200/jco.2017.35.15_suppl.6511  0.14
2019 Dignass A, Waller J, Cappelleri JC, Salese L, Kisser A, Dietz L, DiBonaventura M, Wood R, Bargo D. P782 Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with the treatment of moderate to severe ulcerative colitis in Germany Journal of Crohn's and Colitis. 13: S512-S512. DOI: 10.1093/ecco-jcc/jjy222.906  0.139
2019 Dubinsky M, Bushmakin A, DiBonaventura M, Cappelleri J, Salese L, Maller E, Armuzzi A. P143 Measuring the mediating effects of tofacitinib on health status in ulcerative colitis: data from the OCTAVE programme Journal of Crohn's and Colitis. 13: S161-S161. DOI: 10.1093/ecco-jcc/jjy222.267  0.138
2021 Silverberg JI, Thyssen JP, Simpson EL, Yosipovitch G, Ständer S, Valdez H, Rojo R, Biswas P, Myers DE, Feeney C, DiBonaventura M. Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes. American Journal of Clinical Dermatology. PMID 34406620 DOI: 10.1007/s40257-021-00634-3  0.136
2013 Marrett E, DiBonaventura Md, Zhang Q. Burden of peripheral arterial disease in Europe and the United States: a patient survey. Health and Quality of Life Outcomes. 11: 175. PMID 24148832 DOI: 10.1186/1477-7525-11-175  0.135
2010 DiBonaventura M, Cappelleri J, Joshi A. The relationship between pain severity and health-related quality of life, work productivity, and associated indirect costs in patients with painful diabetic peripheral neuropathy The Journal of Pain. 11: S22. DOI: 10.1016/j.jpain.2010.01.095  0.135
2013 Whiteley J, DiBonaventura Md, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. Journal of Women's Health (2002). 22: 983-90. PMID 24083674 DOI: 10.1089/jwh.2012.3719  0.135
2013 Goren A, DiBonaventura M, Wagner R. Adherence And Its Association With Health Outcomes Among Patients Currently Treated For Leukemia, Melanoma, Or Non-Small Cell Lung Cancer (Nsclc) Value in Health. 16: A144-A145. DOI: 10.1016/J.JVAL.2013.03.709  0.135
2014 Gianoukakis AG, Flores NM, Pelletier CL, DiBonaventura M, Forsythe A, Wolfe G, Rege J, Taylor MH. Treatment Patterns and Health Outcomes Among Patients with Radioiodine-Refractory Differentiated Thyroid Cancer in the United States and Western Europe. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A614. PMID 27202148 DOI: 10.1016/j.jval.2014.08.2159  0.134
2011 Goren A, Gupta S, Dibonaventura M. AD4 Health Outcomes as a Function of Intentional and Unintentional Non-Adherence Among Eleven Costly Conditions in the EU Value in Health. 14: A233. DOI: 10.1016/j.jval.2011.08.012  0.134
2014 Toghanian S, Dibonaventura M, Järbrink K, Locklear JC. Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe. Clinicoeconomics and Outcomes Research : Ceor. 6: 151-63. PMID 24729720 DOI: 10.2147/CEOR.S55429  0.134
2009 Wagner S, Fukuda T, Nagae T, Gupta S, DiBonaventura M, Stankus A. PCV144 HEALTH-RELATED QUALITY OF LIFE AND RESOURCE USE IN PATIENTS WITH METABOLIC SYNDROME: A COMPARISON OF THE UNITED STATES, EUROPE, AND JAPAN Value in Health. 12: A340. DOI: 10.1016/S1098-3015(10)74671-4  0.133
2011 Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 53: 1025-9. PMID 21866052 DOI: 10.1097/JOM.0b013e318229aae4  0.132
2011 DiBonaventura M, Isherwood G, Le Pautremat V, Eschwège E. PDB67 Treatment Patterns and Health Outcomes Among Type 2 Diabetes with Comorbid Obesity in France, Germany, And UK Value in Health. 14: A484. DOI: 10.1016/j.jval.2011.08.1370  0.132
2011 Graham G, Denno M, DiBonaventura M, Gillard PJ, Goren A, Varon SF, Zorowitz RD. Poster 477 Productivity Loss and Indirect Costs Associated With Caring for Patients With Poststroke Spasticity Pm&R. 3: S341-S341. DOI: 10.1016/j.pmrj.2011.08.506  0.131
2018 DiBonaventura M, Souza CDS, Ferreira CN, Carvalho AVE, Squiassi HB. The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil. Anais Brasileiros De Dermatologia. 93: 197-204. PMID 33287965 DOI: 10.1590/abd1806-4841.20186069  0.131
2018 DiBonaventura M, Carvalho AVE, Souza CDS, Squiassi HB, Ferreira CN. The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil. Anais Brasileiros De Dermatologia. 93: 197-204. PMID 29723361 DOI: 10.1590/abd1806-4841.20186069  0.131
2018 DiBonaventura M, Bargo D, Lucas J, Bluff D, Hoskin B, Salese L, Cappelleri JC. The Association Between Disease Activity and Patient-Reported Outcomes in Patients With Moderate-to-Severe Ulcerative Colitis in the United States American Journal of Gastroenterology. 113: S353. DOI: 10.14309/00000434-201810001-00621  0.131
2012 Racketa J, Bushmakin A, DiBonaventura M, Mirkin S. 164 THE EFFECT OF MENOPAUSE-RELATED COMORBIDITIES AND SYMPTOMS ON HEALTH UTILITIES, WORK IMPARIMENT, AND RESOURCE USE AMONG POSTMENOPAUSAL WOMEN IN EUROPE Maturitas. 71: S66. DOI: 10.1016/S0378-5122(12)70275-X  0.131
2015 Bell J, DiBonaventura M, Witt E, Ben-Joseph R, Reeve B. Feasibility Of Using The Sf-36 Health Survey To Screen For Risk Of Major Depressive Disorder Value in Health. 18: A26. DOI: 10.1016/J.Jval.2015.03.161  0.131
2012 Briere J, Rossi B, Iwamoto K, Stankus A, Dibonaventura M. PCV11 Patient Characteristics and Comorbidities of Patients with Atrial Fibrillation in Japan Value in Health. 15: A113. DOI: 10.1016/j.jval.2012.03.614  0.13
2012 Wagner JS, DiBonaventura MD, Chandran AB, Cappelleri JC. The association of sleep difficulties with health-related quality of life among patients with fibromyalgia. Bmc Musculoskeletal Disorders. 13: 199. PMID 23072292 DOI: 10.1186/1471-2474-13-199  0.13
2010 DiBonaventura Md, Wagner S, Waters H, Carter C. Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis. Journal of Drugs in Dermatology : Jdd. 9: 938-44. PMID 20684144  0.13
2013 Suponcic S, DiBonaventura M, Kopenhafer L. Using a life satisfaction measure in the valuation of health: A case study of multiple sclerosis Value in Health. 16: A34. DOI: 10.1016/j.jval.2013.03.198  0.129
2019 Dubinsky M, Bushmakin AG, DiBonaventura Md, Cappelleri JC, Salese L, Maller ES, Armuzzi A. Sa1872 – Measuring the Mediating Effects of Tofacitinib on Health Status in Ulcerative Colitis: Data from the Octave Program Gastroenterology. 156: S-437. DOI: 10.1016/S0016-5085(19)37938-7  0.129
2015 Ganapathy V, Graham GD, DiBonaventura MD, Gillard PJ, Goren A, Zorowitz RD. Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity. Clinical Interventions in Aging. 10: 1793-1802. PMID 26609225 DOI: 10.2147/CIA.S91123  0.128
2019 Quon P, Sardesai A, Milev S, DiBonaventura M, Cappelleri J, Kisser A, Modesto I, Dietz L, Dignass A, Bargo D. PGI9 COST-EFFECTIVENESS OF TOFACITINIB COMPARED WITH INFLIXIMAB, ADALIMUMAB, GOLIMUMAB AND VEDOLIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS IN GERMANY Value in Health. 22: S617. DOI: 10.1016/j.jval.2019.09.1132  0.128
2012 Dibonaventura MD, Wagner JS, Alvir J, Whiteley J. Depression, quality of life, work productivity, resource use, and costs among women experiencing menopause and hot flashes: a cross-sectional study. The Primary Care Companion For Cns Disorders. 14. PMID 23586001 DOI: 10.4088/PCC.12m01410  0.127
2019 Kudel I, Hopps M, Cappelleri JC, Sadosky A, King-Concialdi K, Liebert R, Parsons B, Hlavacek P, Alexander AH, DiBonaventura MD, Markman JD, Farrar JT, Stacey BR. Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam. Journal of Pain Research. 12: 255-268. PMID 30662281 DOI: 10.2147/Jpr.S160513  0.127
2013 Dibonaventura MD, Chandran A, Hsu MA, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. International Journal of Women's Health. 5: 261-9. PMID 23737678 DOI: 10.2147/IJWH.S39027  0.127
2012 Pignot M, Eichmann F, Dibonaventura M. PMD74 The Relationship Between Treatment Satisfaction and Health Status among Those With Type 1 Diabetes Value in Health. 15: A358. DOI: 10.1016/J.JVAL.2012.08.923  0.126
2015 DiBonaventura MD, Piedade A, Flores NM. The Association Between Tolerability Issues and Health Outcomes Among Patients with Hcv in Brazil. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A873. PMID 26534676 DOI: 10.1016/j.jval.2015.09.023  0.126
2015 DiBonaventura M, Lay AL, Kumar M, Hammer M, Wolden ML. The Association Between Body Mass Index and Health and Economic Outcomes in the United States. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1047-54. PMID 26461859 DOI: 10.1097/JOM.0000000000000539  0.125
2016 Uemura H, Matsubara N, Kimura G, Yamaguchi A, Ledesma DA, DiBonaventura M, Mohamed AF, Basurto E, McKinnon I, Wang E, Concialdi K, Narimatsu A, Aitoku Y. Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. Bmc Urology. 16: 63. PMID 27814714 DOI: 10.1186/s12894-016-0182-2  0.125
2011 DiBonaventura M, Link C, Pollack MF, Wagner JS, Williams SA. The relationship between patient-reported tolerability issues with oral antidiabetic agents and work productivity among patients having type 2 diabetes. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 53: 204-10. PMID 21270651 DOI: 10.1097/JOM.0b013e318209e0ce  0.123
2016 Lasch K, Liu S, Ursos L, Mody R, King-Concialdi K, DiBonaventura M, Leberman J, Dubinsky M. Gastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey. Advances in Therapy. PMID 27509887 DOI: 10.1007/s12325-016-0393-7  0.122
2016 Goren A, Strader C, DiBonaventura M. PREVALENCE AND HEALTH OUTCOMES ASSOCIATED WITH TYPES OF DIABETES COMPLICATIONS Value in Health. 19: A206-A207. DOI: 10.1016/j.jval.2016.03.1259  0.122
2010 DiBonaventura MD, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W. Humanistic and economic impacts of hepatitis C infection in the United States. Journal of Medical Economics. 13: 709-18. PMID 21091098 DOI: 10.3111/13696998.2010.535576  0.12
2019 Armuzzi A, Tarallo M, Bargo D, Lucas J, Bluff D, Hoskin B, Salese L, Cappelleri J, Kayhan C, DiBonaventura M. P255 Perceived disease severity and treatment satisfaction among patients with ulcerative colitis in Europe Journal of Crohn's and Colitis. 13: S224-S225. DOI: 10.1093/ecco-jcc/jjy222.379  0.12
2013 Vanderpoel J, Schenkel B, Lofland J, DiBonaventura M, Gross H. Comparison of clinical and cost characteristics among patients with inflammatory bowel disease across different sites of care Value in Health. 16: A122. DOI: 10.1016/J.Jval.2013.03.585  0.12
2024 Sinyavskaya L, Meche A, Faucher A, Hlavacek P, Johnson SM, DiBonaventura M, Vekeman F, Ren J, Schepart A. Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data. Current Medical Research and Opinion. 1-19. PMID 38523576 DOI: 10.1080/03007995.2024.2333439  0.12
2024 Mohty M, Bahlis NJ, Nooka AK, DiBonaventura M, Ren J, Conte U. Impact of elranatamab on quality of life: Patient-reported outcomes from MagnetisMM-3. British Journal of Haematology. PMID 38420657 DOI: 10.1111/bjh.19346  0.12
2024 Costa LJ, LeBlanc TW, Tesch H, Sonneveld P, Kyle RP, Sinyavskaya L, Hlavacek P, Meche A, Ren J, Schepart A, Aydin D, Nador G, DiBonaventura MD. Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future Oncology (London, England). PMID 38415370 DOI: 10.2217/fon-2023-0995  0.12
2016 Ding B, DiBonaventura M, Karlsson N, Ling X. Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys. International Journal of Chronic Obstructive Pulmonary Disease. 11: 1139-50. PMID 27354777 DOI: 10.2147/COPD.S103873  0.12
2014 Dibonaventura MD, Yuan Y, Lescrauwaet B, L'italien G, Liu GG, Kamae I, Mauskopf JA. Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: a patient survey. Plos One. 9: e86070. PMID 24465875 DOI: 10.1371/journal.pone.0086070  0.119
2011 LaMori J, Gross H, Patel A, Crain M, DiBonaventura M, Mody S, Schein J. PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION Value in Health. 14: A34. DOI: 10.1016/J.JVAL.2011.02.201  0.119
2016 Lee L, DiBonaventura M, Kudel I, Schepart A, Kellstein D. THE INCREMENTAL EFFECT OF OVER-THE-COUNTER MEDICATIONS ON WORK PRODUCTIVITY AND HEALTH CARE RESOURCE UTILIZATION AMONG ADULTS WITH PAIN IN THE UNITED STATES Value in Health. 19: A250. DOI: 10.1016/j.jval.2016.03.1074  0.118
2013 Wagner JS, Chandran A, DiBonaventura M, Cappelleri JC. The costs associated with sleep symptoms among patients with fibromyalgia. Expert Review of Pharmacoeconomics & Outcomes Research. 13: 131-9. PMID 23402453 DOI: 10.1586/erp.12.82  0.117
2018 DiBonaventura M, Nicolucci A, Meincke H, Le Lay A, Fournier J. Obesity in Germany and Italy: prevalence, comorbidities, and associations with patient outcomes. Clinicoeconomics and Outcomes Research : Ceor. 10: 457-475. PMID 30197528 DOI: 10.2147/CEOR.S157673  0.117
2020 Eichenfield LF, DiBonaventura M, Xenakis J, Lafeuille MH, Duh MS, Fakih I, Levenberg M, Cappelleri JC, Sikirica V. Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database. Dermatology and Therapy. 10: 791-806. PMID 32607738 DOI: 10.1007/s13555-020-00413-8  0.117
2019 Yu SY, Fan BF, Yang F, DiBonaventura M, Chen YX, Li RY, King-Concialdi K, Kudel I, Hlavacek P, Hopps M, Udall M, Sadosky A, Cappelleri JC. Patient and economic burdens of postherpetic neuralgia in China. Clinicoeconomics and Outcomes Research : Ceor. 11: 539-550. PMID 31564930 DOI: 10.2147/CEOR.S203920  0.116
2012 DiBonaventura M, Fukuda T, Stankus A. PDB30 The Prevalence and Burden of Comorbid Hypertension and Obesity among Patients With Type 2 Diabetes in Japan Value in Health. 15: A664. DOI: 10.1016/J.JVAL.2012.08.361  0.116
2012 Schmeichel-Mueller C, Goren A, DiBonaventura M, Martin S. PSS27 Relationship Between Weight and Dose in Psoriasis Patients Treated with Ustekinumab Value in Health. 15: A254-A255. DOI: 10.1016/j.jval.2012.03.1371  0.116
2011 Naim A, DiBonaventura M, Bolge S. PMS36 EXAMINING THE RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS Value in Health. 14: A129. DOI: 10.1016/j.jval.2011.02.721  0.116
2015 Zhang M, Goren A, Lee S, DiBonaventura MD, Olson WH. Characterizing Patients with Psoriasis on Injectable Biologics Adalinumab, Etanercept, and Ustekinumab: A Chart Review Study. The Journal of Dermatological Treatment. 1-24. PMID 26558924 DOI: 10.3109/09546634.2015.1118427  0.115
2021 Gooderham MJ, Chu CY, Rojo R, Valdez H, Biswas P, Cameron MC, Feeney C, Encinas GA, Peeples-Lamirande K, Cappelleri JC, Myers DE, DiBonaventura M. Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE. Jaad International. 4: 46-48. PMID 34409391 DOI: 10.1016/j.jdin.2021.05.004  0.115
2015 Parasuraman S, DiBonaventura M, Reith K, Naim A, Concialdi K, Sarlis NJ. Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: a chart review. Experimental Hematology & Oncology. 5: 3. PMID 26839736 DOI: 10.1186/s40164-016-0031-8  0.114
2019 Dubinsky M, Bressler B, Armuzzi A, Salese L, DiBonaventura Md, Maller ES, Fan H, Woodworth DA, Su C. Tu1730 – Improvement in Patient-Reported Inflammatory Bowel Disease Questionnaire Outcomes, and Relationship with Disease Activity, in Tofacitinib-Treated Patients with Ulcerative Colitis: Data from the Octave Clinical Trials Gastroenterology. 156: S-1102. DOI: 10.1016/S0016-5085(19)39716-1  0.114
2012 Kinoshita Y, DiBonaventura M, Wang E, Rossi B, Iwamoto K, Stankus A, Briere J. PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in Japan Value in Health. 15: A379-A380. DOI: 10.1016/j.jval.2012.08.1040  0.112
2016 Ding B, DiBonaventura M, Karlsson N, Ling X. A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 0. PMID 28001469 DOI: 10.1080/02770903.2016.1255750  0.111
2018 Sung VW, Iyer RG, Gandhi SK, Shah-Manek B, DiBonaventura M, Abler V, Claassen DO. Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States. Current Medical Research and Opinion. 1-13. PMID 29383957 DOI: 10.1080/03007995.2018.1435518  0.111
2011 Vanderpoel J, Lofland J, DiBonaventura M, Orlic Z. Association of treatment satisfaction with healthcare resource utilization, quality of life and work productivity among patients with Inflammatory Bowel Disease currently using biologic treatment Inflammatory Bowel Diseases. 17: S31-S32. DOI: 10.1097/00054725-201112002-00100  0.11
2019 Dubinsky MC, Bressler B, Armuzzi A, Salese L, DiBonaventura M, Maller E, Fan H, Woodworth DA, Su C. P685 Improvement in patient-reported Inflammatory Bowel Disease Questionnaire outcomes, and relationship with disease activity, in tofacitinib-treated patients with ulcerative colitis: Data from the OCTAVE clinical trials Journal of Crohn's and Colitis. 13: S462-S463. DOI: 10.1093/ecco-jcc/jjy222.809  0.11
2015 Takura T, Ushida T, Kanchiku T, Ebata N, Fujii K, DiBonaventura Md, Taguchi T. The societal burden of chronic pain in Japan: an internet survey. Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association. 20: 750-60. PMID 25963609 DOI: 10.1007/s00776-015-0730-8  0.11
2011 Wagner J, DiBonaventura M, Balu S, Buchner D. Economic Burden of Patients With GERD Showing Both Day-Time and Night-Time Heartburn Symptoms Gastroenterology. 140: S-389-S-390. DOI: 10.1016/S0016-5085(11)61597-7  0.109
2012 Dibonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. Bmc Psychiatry. 12: 20. PMID 22433036 DOI: 10.1186/1471-244X-12-20  0.109
2012 DiBonaventura M, Liu G, Stankus A. PDB31 The Prevalence and Burden of Comorbid Hypertension and Obesity Among Patients With Type 2 Diabetes in Urban China Value in Health. 15: A664. DOI: 10.1016/j.jval.2012.08.362  0.108
2010 DiBonaventura M, Cappelleri J, Joshi A. The incremental and extended impact of painful diabetic peripheral neuropathy on health outcomes over time The Journal of Pain. 11: S2. DOI: 10.1016/j.jpain.2010.01.013  0.108
2012 DiBonaventura Md, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H. The burden of chronic obstructive pulmonary disease among employed adults. International Journal of Chronic Obstructive Pulmonary Disease. 7: 211-9. PMID 22500121 DOI: 10.2147/COPD.S29280  0.108
2012 Choi J, Dibonaventura M, Kopenhafer L, Nelson W. PCV79 Survey of Patients with Atrial Fibrillation on the Use of Warfari and Dabigatran Value in Health. 15: A126. DOI: 10.1016/j.jval.2012.03.682  0.107
2019 Maculaitis M, DiBonaventura MD, Goren A, Li V, Lawendy N, Bargo D, Cappelleri J, Salese L. P025 PERCEIVED DISEASE CONTROL AND TREATMENT SATISFACTION AMONG PATIENTS WITH ULCERATIVE COLITIS IN THE UNITED STATES Gastroenterology. 156: S18. DOI: 10.1053/j.gastro.2019.01.074  0.106
2012 DiBonaventura M, Liu G, Zhang W, Liu X, Stankus A. PRS7 The Effect of Chronic Obstructive Pulmonary Disease (COPD) on Health Status in Urban China Value in Health. 15: A641. DOI: 10.1016/j.jval.2012.08.228  0.105
2010 Finkelstein EA, DiBonaventura Md, Burgess SM, Hale BC. The costs of obesity in the workplace. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 52: 971-6. PMID 20881629 DOI: 10.1097/JOM.0b013e3181f274d2  0.105
2018 DiBonaventura M, Bargo D, Lucas J, Bluff D, Hoskin B, Salese L, Cappelleri JC, Quirk D. Treatment Patterns Among Patients With Moderate-to-Severe Ulcerative Colitis in the United States American Journal of Gastroenterology. 113: S354. DOI: 10.14309/00000434-201810001-00623  0.105
2013 Suponcic S, DiBonaventura M, Victor T. Identifying patient subpopulations in early development to substantiate value Value in Health. 16: A42. DOI: 10.1016/j.jval.2013.03.238  0.104
2012 Finkelstein EA, Allaire BT, Dibonaventura MD, Burgess SM. Incorporating indirect costs into a cost-benefit analysis of laparoscopic adjustable gastric banding. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 299-304. PMID 22433761 DOI: 10.1016/j.jval.2011.12.004  0.103
2016 Yamamoto LA, DiBonaventura M, Kawaguchi I. The association between osteoporosis and patient outcomes in Japan. Journal of Medical Economics. 1-27. PMID 26929988 DOI: 10.3111/13696998.2016.1159567  0.103
2019 Chapman J, DiBonaventura MD, Comerford E, Louder A, Smith T, Lawendy N, Maller E, Kayhan C, Gruben D, Soonasra A. P068 EXTRAINTESTINAL MANIFESTATIONS AND THEIR IMPACT ON REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ULCERATIVE COLITIS Gastroenterology. 156: S47-S48. DOI: 10.1053/j.gastro.2019.01.127  0.102
2012 Suponcic S, DiBonaventura M, Victor T. PSY47 The Relationship Between Pain Severity and Health Utilities: Informing Clinical Trial Design to Substantiate Value Value in Health. 15: A517. DOI: 10.1016/j.jval.2012.08.1770  0.102
2018 Shah-Manek B, Wong W, Ravelo A, DiBonaventura M. Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey. Journal of Managed Care & Specialty Pharmacy. 1-9. PMID 29451078 DOI: 10.18553/jmcp.2018.17449  0.101
2010 Dibonaventura MD, Wagner JS, Girman CJ, Brodovicz K, Zhang Q, Qiu Y, Pentakota SR, Radican L. Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication. Patient Preference and Adherence. 4: 397-406. PMID 21206515 DOI: 10.2147/PPA.S14477  0.101
2016 DiBonaventura M, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri J, Hlavacek P, Alexander A, Stacey B, Markman J, Farrar J. (143) The prevalence of broad neuropathic pain in the United States: results from a multi-channel general population health survey. The Journal of Pain : Official Journal of the American Pain Society. 17: S11. PMID 28162349 DOI: 10.1016/j.jpain.2016.01.046  0.101
2012 Mori A, Goren A, Gilloteau I, Dibonaventura M. Quantifying the Burden of Caregiving for Patients with Cancer in Europe Annals of Oncology. 23: ixe25-ixe26. DOI: 10.1016/s0923-7534(20)34348-9  0.101
2010 DiBonaventura M, Cappelleri J, Joshi A. The impact of pain severity on healthcare resource use and associated direct costs in patients with painful diabetic peripheral neuropathy The Journal of Pain. 11: S22. DOI: 10.1016/j.jpain.2010.01.096  0.1
2019 Long MD, Smith TW, Dibonaventura M, Gruben D, Bargo D, Salese L, Quirk D. Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States. Inflammatory Bowel Diseases. PMID 31560046 DOI: 10.14309/00000434-201810001-00624  0.098
2020 Armuzzi A, DiBonaventura MD, Tarallo M, Lucas J, Bluff D, Hoskin B, Bargo D, Cappelleri JC, Quirk D, Salese L. Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe. Plos One. 15: e0227914. PMID 31945774 DOI: 10.1371/journal.pone.0227914  0.098
2021 Long MD, Cohen RD, Smith TW, DiBonaventura M, Gruben D, Bargo D, Salese L, Quirk D. Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis. Digestive Diseases (Basel, Switzerland). PMID 34879378 DOI: 10.1159/000521299  0.098
2012 Pignot M, Eichmann F, DiBonaventura M. PMD76 The Effect of Insulin Pump Therapy on Health Status Among Those With Type 1 Diabetes Value in Health. 15: A358. DOI: 10.1016/J.JVAL.2012.08.925  0.097
2016 Jaffe D, Flaks-Manov N, Benis A, Gabay H, DiBonaventura M, Rosenbaum H, Joseph A, Leventer-Roberts M. A Population-Based Cohort of Gaucher Disease Patients Identified Using EHR Data Value in Health. 19: A578. DOI: 10.1016/j.jval.2016.09.1335  0.096
2021 Egeberg A, Anderson P, Piercy J, Massey L, Cappelleri JC, Encinas GA, Feeney C, Dibonaventura M. Symptom burden of patients with moderate-to-severe atopic dermatitis. European Journal of Dermatology : Ejd. PMID 34935621 DOI: 10.1684/ejd.2021.4166  0.096
2015 DiBonaventura MD, Le Lay A, Fournier J, Kull K, Olmos HC, Mille I, Bjørke B, Bakker E, Ehrenreich A. The Burden of Obesity in Mexico: Prevalence, Comorbidities, and Associations With Quality of Life, Resource Utilization and Productivity. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A843. PMID 26534508 DOI: 10.1016/j.jval.2015.09.389  0.096
2015 Foster SA, Shortridge EF, DiBonaventura M, Viktrup L. Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey. World Journal of Urology. 33: 639-47. PMID 25100623 DOI: 10.1007/s00345-014-1366-6  0.095
2013 de Renteria J, DiBonaventura M, Suponcic S, Pomerantz D. Unmet Needs and Biologic Use Among Patients with Rheumatoid Arthritis in Brazil Value in Health. 16: A719. DOI: 10.1016/j.jval.2013.08.2236  0.095
2012 Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, Dibonaventura MD, Carroll CF, Allen JK, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 143: 1179-87.e1-3. PMID 22885331 DOI: 10.1053/J.Gastro.2012.08.002  0.095
2012 Liu GG, DiBonaventura Md, Yuan Y, Wagner JS, L'Italien GJ, Langley P, Kamae I. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: S65-71. PMID 22265070 DOI: 10.1016/j.jval.2011.11.012  0.095
2016 DiBonaventura M, Higginbottom K, Meyers A, Morimoto Y, Ilacqua J. Comparative Effectiveness of Crizotinib Among ALK+ NSCLC Patients Across The United States, Western Europe, and Japan Value in Health. 19: A711. DOI: 10.1016/J.JVAL.2016.09.2091  0.094
2019 Dignass A, Waller J, Cappelleri JC, Salese L, Kisser A, Dietz L, DiBonaventura M, Wood R, Bargo D. P746 Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis Journal of Crohn's and Colitis. 13: S495-S495. DOI: 10.1093/ECCO-JCC/JJY222.870  0.093
2019 Yang F, Yu S, Fan B, Liu Y, Chen YX, Kudel I, Concialdi K, DiBonaventura M, Hopps M, Hlavacek P, Cappelleri JC, Sadosky A, Parsons B, Udall M. The Epidemiology of Herpes Zoster and Postherpetic Neuralgia in China: Results from a Cross-Sectional Study. Pain and Therapy. PMID 31218562 DOI: 10.1007/s40122-019-0127-z  0.093
2012 Gwaltney C, Kopenhafer L, Victor T, Dibonaventura M, Gruenberger J, Ong S. PDB59 Content Validity of a New Patient-Reported Outcome Instrument to Assess Hypoglycemia: The Hypoglycemia Perspectives Questionnaire Value in Health. 15: A504. DOI: 10.1016/j.jval.2012.08.1702  0.093
2011 Anhoury P, DiBonaventura M, Wagner R. Health-related quality of life among women with a history of breast cancer in Europe. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e19615. PMID 28022110 DOI: 10.1200/jco.2011.29.15_suppl.e19615  0.093
2022 Ständer S, Kwatra SG, Silverberg JI, Simpson EL, Thyssen JP, Yosipovitch G, Zhang F, Cameron MC, Cella RR, Valdez H, DiBonaventura M, Feeney C. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial. American Journal of Clinical Dermatology. PMID 36512175 DOI: 10.1007/s40257-022-00738-4  0.091
2019 Jaffe DH, Flaks-Manov N, Benis A, Gabay H, DiBonaventura M, Rosenbaum H, Joseph A, Bachrach A, Leventer-Roberts M. Population-based cohort of 500 patients with Gaucher disease in Israel. Bmj Open. 9: e024251. PMID 30670517 DOI: 10.1136/bmjopen-2018-024251  0.09
2019 Dubinsky MC, DiBonaventura M, Fan H, Bushmakin AG, Cappelleri JC, Maller E, Thorpe AJ, Salese L, Panés J. 701 Item-Level Improvements in Inflammatory Bowel Disease Questionnaire Scores in Patients With Ulcerative Colitis Treated With Tofacitinib Induction Therapy American Journal of Gastroenterology. 114: S413-S413. DOI: 10.14309/01.ajg.0000592340.59713.ab  0.089
2018 DiBonaventura MD, Wong W, Shah-Manek B, Schulz M. Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA. Oncotargets and Therapy. 11: 75-82. PMID 29317835 DOI: 10.2147/OTT.S144960  0.088
2021 Blauvelt A, Silverberg JI, Lynde CW, Bieber T, Eisman S, Zdybski J, Gubelin W, Simpson EL, Valenzuela F, Criado PR, Lebwohl MG, Feeney C, Khan T, Biswas P, DiBonaventura M, et al. Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: results from the JADE REGIMEN phase 3 trial. Journal of the American Academy of Dermatology. PMID 34416294 DOI: 10.1016/j.jaad.2021.05.075  0.088
2011 Wagner JS, DiBonaventura MD, Balu S, Buchner D. The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms. Expert Review of Pharmacoeconomics & Outcomes Research. 11: 739-49. PMID 22098290 DOI: 10.1586/erp.11.72  0.087
2013 DiBonaventura M, Wintfeld N, Huang J, Goren A. Assessing adherence among patients with type 2 diabetes using insulin: Psychometric analysis of the morisky medication adherence scale Value in Health. 16: A168. DOI: 10.1016/J.JVAL.2013.03.840  0.086
2011 LaMori J, Gross H, Patel A, Crain M, DiBonaventura M, Mody S, Schein J. PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF) Value in Health. 14: A34. DOI: 10.1016/J.JVAL.2011.02.202  0.086
2021 Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, et al. Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary. Immunotherapy. PMID 34775830 DOI: 10.2217/imt-2021-0224  0.086
2020 Dubinsky MC, DiBonaventura M, Fan H, Bushmakin AG, Cappelleri JC, Maller E, Thorpe AJ, Salese L, Panés J. Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies. Inflammatory Bowel Diseases. PMID 32794567 DOI: 10.1093/ibd/izaa193  0.086
2011 Gupta S, Wagner J, Goren A, DiBonaventura M. PCV72 THE RISK OF STROKE AND PREVENTATIVE STEPS AMONG PATIENTS DIAGNOSED WITH ATRIAL FIBRILLATION IN THE UNITED STATES Value in Health. 14: A45. DOI: 10.1016/j.jval.2011.02.259  0.085
2011 Chandran A, Wagner J, DiBonaventura M, Cappelleri J. T-O-135 THE COSTS ASSOCIATED WITH SLEEP DIFFICULTIES AMONG PATIENTS WITH FIBROMYALGIA Sleep Medicine. 12: S93-S94. DOI: 10.1016/S1389-9457(11)70348-3  0.085
2010 Naim A, DiBonaventura M, Freedman D, Waters HC. T1061 Determining Work Loss and Productivity Changes Due to Disability Among Individuals With Crohn's Disease – Results From a National Survey Gastroenterology. 138: S-479. DOI: 10.1016/S0016-5085(10)62216-0  0.085
2011 DiBonaventura Md, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W. The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. Journal of Medical Economics. 14: 253-61. PMID 21385147 DOI: 10.3111/13696998.2011.566294  0.084
2022 Wu JJ, Chih-Ho Hong H, Merola JF, Gruben D, Güler E, Feeney C, Bhambri A, Myers DE, DiBonaventura M. Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. PMID 35640774 DOI: 10.1016/j.anai.2022.05.025  0.084
2012 Dibonaventura M, Kontsevaya A, Isherwood G. PDB62 Type 2 Diabetes in Russia: Prevalence, Risk Factors, and Burden Value in Health. 15: A505. DOI: 10.1016/J.JVAL.2012.08.1705  0.083
2012 DiBonaventura M, Wintfeld N, Goren A. PDB65 The Association Between Non-Adherence and HbA1c Among Type 2 Diabetes Patients Using Basal Insulin Analogues Value in Health. 15: A182. DOI: 10.1016/J.JVAL.2012.03.986  0.083
2021 Ervin C, Crawford R, Evans E, Feldman SR, Zeichner J, Zielinski M, Cappelleri JC, DiBonaventura M, Takiya L, Myers DE. Patient and Caregiver Preferences on Treatment Attributes for Atopic Dermatitis. The Journal of Dermatological Treatment. 1-30. PMID 34264145 DOI: 10.1080/09546634.2021.1940810  0.083
2016 Buchs S, Weatherall J, DiBonaventura M, Wisniewski T. Non-Adherent Behaviour and Glycaemic Control in Patients with Type 2 Diabetes Treated with Insulin Value in Health. 19: A676. DOI: 10.1016/j.jval.2016.09.1894  0.082
2011 McDonald M, DiBonaventura Md, Ullman S. Musculoskeletal pain in the workforce: the effects of back, arthritis, and fibromyalgia pain on quality of life and work productivity. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 53: 765-70. PMID 21685799 DOI: 10.1097/JOM.0b013e318222af81  0.082
2015 DiBonaventura M, Luo X, Moffatt M, Bushmakin AG, Kumar M, Bobula J. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe. Journal of Women's Health (2002). 24: 713-22. PMID 26199981 DOI: 10.1089/jwh.2014.5177  0.082
2020 Silverberg JI, Simpson EL, Thyssen JP, Gooderham M, Chan G, Feeney C, Biswas P, Valdez H, DiBonaventura M, Nduaka C, Rojo R. Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. Jama Dermatology. PMID 32492087 DOI: 10.1001/Jamadermatol.2020.1406  0.082
2017 Kudel I, Hopps M, Cappelleri J, Sadosky A, Concialdi K, Liebert R, Parsons B, Hlavacek P, Alexander A, DiBonaventura M, Markman J, Farrar J, Stacey B. (424) Characteristics of patients with neuropathic pain screened by the painDETECT and diagnosed by physician exam The Journal of Pain. 18: S80. DOI: 10.1016/j.jpain.2017.02.274  0.082
2017 Wong WB, Ravelo A, DiBonaventura M, Shah-Manek B. Oncologists’ awareness, knowledge, and perceptions of value frameworks. Journal of Clinical Oncology. 35: e18317-e18317. DOI: 10.1200/jco.2017.35.15_suppl.e18317  0.081
2018 Claassen DO, Iyer RG, Shah-Manek B, DiBonaventura M, Abler V, Sung VW. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review. Journal of Huntington's Disease. PMID 30282372 DOI: 10.3233/JHD-170286  0.08
2020 Curtis JR, Regueiro M, Yun H, Su C, DiBonaventura M, Lawendy N, Nduaka CI, Koram N, Cappelleri JC, Chan G, Modesto I, Lichtenstein GR. Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data. Inflammatory Bowel Diseases. PMID 33324993 DOI: 10.1093/ibd/izaa289  0.08
2018 ALEMAYEHU B, NGUYEN AM, DIBONAVENTURA M, SHAH-MANEK B, KARKI C, CRUTCHLOW M. Predictors of Preferences for Use of MK-1293 Pens among Patients with Diabetes—Findings from a Multinational Study in the U.S., Canada, and U.K. Diabetes. 67: 2272-PUB. DOI: 10.2337/db18-2272-PUB  0.08
2011 Hay J, DiBonaventura M, Baser R, Press N, Shoveller J, Bowen D. Personal attributions for melanoma risk in melanoma-affected patients and family members. Journal of Behavioral Medicine. 34: 53-63. PMID 20809355 DOI: 10.1007/S10865-010-9286-4  0.08
2023 Ren J, Cislo P, Cappelleri JC, Hlavacek P, DiBonaventura M. Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study. Bmc Medical Research Methodology. 23: 18. PMID 36647031 DOI: 10.1186/s12874-023-01835-6  0.079
2015 Lee L, Velez F, Pomerantz D, DiBonaventura M. Treatment Satisfaction Among Patients treated with Monotherapy And Adjunctive Antiepileptic Drug Therapies Value in Health. 18: A287. DOI: 10.1016/j.jval.2015.03.1676  0.078
2023 Reich K, Thyssen JP, Blauvelt A, Eyerich K, Soong W, Rice ZP, Hong HC, Katoh N, Valenzuela F, DiBonaventura M, Bratt TA, Zhang F, Clibborn C, Rojo R, Valdez H, et al. Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary. Immunotherapy. PMID 37254941 DOI: 10.2217/imt-2022-0306  0.078
2016 Ebata N, Lee L, Hlavacek P, DiBonaventura M, Cappelleri J, Sadosky A. The Economic Burden of Fibromyalgia in Japan Value in Health. 19: A881. DOI: 10.1016/j.jval.2016.08.306  0.077
2023 Yosipovitch G, Gooderham MJ, Ständer S, Fonacier L, Szepietowski JC, Deleuran M, Girolomoni G, Su JC, Bushmakin AG, Cappelleri JC, Feeney C, Chan G, Thorpe AJ, Valdez H, Biswas P, ... ... DiBonaventura M, et al. Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2. American Journal of Clinical Dermatology. PMID 37624488 DOI: 10.1007/s40257-023-00810-7  0.076
2011 Wagner J, DiBonaventura M, Shah S, Alvir J, Whiteley J. PIH32 THE ASSOCIATION OF MENOPAUSAL SYMPTOMS, INCLUDING HOT FLASHES, WITH QUALITY OF LIFE, WORK PRODUCTIVITY AND RESOURCE USE Value in Health. 14: A111. DOI: 10.1016/J.JVAL.2011.02.617  0.076
2014 Choi JC, Dibonaventura MD, Kopenhafer L, Nelson WW. Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation. Patient Preference and Adherence. 8: 167-77. PMID 24532967 DOI: 10.2147/PPA.S56187  0.076
2022 Blauvelt A, Boguniewicz M, Brunner PM, Luna PC, Biswas P, DiBonaventura M, Farooqui SA, Rojo R, Cameron MC. Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life. The Journal of Dermatological Treatment. 1-33. PMID 35763326 DOI: 10.1080/09546634.2022.2059053  0.075
2010 DiBonaventura M, Paulose-Ram R, Su J, Mcdonald M, Zou K, Wagner J, Shah H. PRS39 QUALITY OF LIFE, PRODUCTIVITY LOSS, AND RESOURCE USE AMONG EMPLOYED ADULTS AGED 40 TO 64 YEARS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UNITED STATES (US) WORKFORCE Value in Health. 13: A326. DOI: 10.1016/S1098-3015(11)72271-9  0.075
2023 Simpson EL, Silverberg JI, Thyssen JP, Viguier M, Thaçi D, de Bruin-Weller M, Weidinger S, Chan G, DiBonaventura M, Biswas P, Feeney C, Koulias C, Cork MJ. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial. American Journal of Clinical Dermatology. PMID 37213005 DOI: 10.1007/s40257-023-00785-5  0.074
2011 Moisan C, Eschwège E, Basdevant A, Charles M, DiBonaventura M, Bonnélye G. PDB83 The Epidemiology and Burden of Obesity and Diabetes in France: A Methodological Comparison Value in Health. 14: A487. DOI: 10.1016/J.JVAL.2011.08.1386  0.074
2010 Naim A, DiBonaventura M, Freedman D, Waters HC. T1062 Assessing Work Productivity Loss and Disability Among Individuals With Ulcerative Colitis in the United States Gastroenterology. 138: S-480. DOI: 10.1016/S0016-5085(10)62217-2  0.074
2023 Reich K, Silverberg JI, Papp KA, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin-Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Johnson S, Farooqui SA, et al. Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 37335885 DOI: 10.1111/jdv.19280  0.073
2010 DiBonaventura M, Paulose-Ram R, Su J, McDonald M, Zou K, Wagner J, Shah H. The Impact of Chronic Obstructive Pulmonary Disease (COPD) on Quality of Life, Productivity Loss, and Resource Use Among the Elderly United States (US) Workforce Chest. 138: 442A. DOI: 10.1378/chest.10243  0.073
2019 DiBonaventura MD, Shah-Manek B, Higginbottom K, Penrod JR, Yuan Y. Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan. Therapeutics and Clinical Risk Management. 15: 355-366. PMID 30881001 DOI: 10.2147/TCRM.S183216  0.072
2011 DiBonaventura M, Annunziata K, Goren A, Gupta S. PRM15 ADHERENCE IS ADHERENCE IS ADHERENCE: THE CONSISTENCY OF MORISKY ADHERENCE SCORES ACROSS THE COSTLIEST CHRONIC CONDITIONS Value in Health. 14: A148. DOI: 10.1016/j.jval.2011.02.823  0.072
2020 Yarlas A, Maher S, Bayliss M, Lovley A, Cappelleri JC, Bushmakin AG, DiBonaventura MD. The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis. Journal of Patient-Centered Research and Reviews. 7: 189-205. PMID 32377552 DOI: 10.17294/2330-0698.1722  0.072
2010 Zorowitz RD, Burk CT, DiBonaventura M, Ertl J, Graham GD, Varon SF. Poster 223: Burden of Caregiving for Patients With Spasticity Due to Stroke or Multiple Sclerosis Pm&R. 2: S101-S101. DOI: 10.1016/j.pmrj.2010.07.256  0.072
2021 Eichenfield LF, Flohr C, Sidbury R, Siegfried E, Szalai Z, Galus R, Yao Z, Takahashi H, Barbarot S, Feeney C, Zhang F, DiBonaventura M, Rojo R, Valdez H, Chan G. Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial. Jama Dermatology. PMID 34406366 DOI: 10.1001/jamadermatol.2021.2830  0.07
2022 Reich K, Lio PA, Bissonnette R, Alexis AF, Lebwohl MG, Pink AE, Kabashima K, Boguniewicz M, Nowicki RJ, Valdez H, Zhang F, DiBonaventura M, Cameron MC, Clibborn C. Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis. The Journal of Allergy and Clinical Immunology. in Practice. PMID 36108923 DOI: 10.1016/j.jaip.2022.08.042  0.07
2009 Wagner S, Fukuda T, Nagae T, Gupta S, DiBonaventura M, Stankus A. PCV150 WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH METABOLIC SYNDROME: A COMPARISON OF THE UNITED STATES, EUROPE, AND JAPAN Value in Health. 12: A341. DOI: 10.1016/S1098-3015(10)74677-5  0.068
2010 Goren A, DiBonaventura M, Gupta S, Wagner J, Freedman D. PIH27 ADHERENCE TO PRESCRIPTION MEDICATIONS IS HIGHER WITH USE OF A GENERAL PRACTITIONER Value in Health. 13: A379-A380. DOI: 10.1016/S1098-3015(11)72542-6  0.068
2022 Wu JJ, Lafeuille MH, Emond B, Fakih I, Duh MS, Cappelleri JC, Yin N, Feeney C, Myers DE, DiBonaventura M. Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis. Advances in Therapy. PMID 35821555 DOI: 10.1007/s12325-022-02197-z  0.068
2014 DiBonaventura M, Copher R, Basurto E, Faria C, Lorenzo R. Patient Preferences Of Treatments Among Women With Metastatic Breast Cancer: Results From A Conjoint Analysis Study Value in Health. 17: A4. DOI: 10.1016/J.JVAL.2014.03.028  0.068
2011 Dibonaventura M, Isherwood G, Buenestado B, Manso M. PHP88 Societal Unmet Needs within Spain Value in Health. 14: A349. DOI: 10.1016/j.jval.2011.08.639  0.066
2018 ALEMAYEHU B, DIBONAVENTURA M, NGUYEN AM, CRUTCHLOW M. Preference Differences between Insulin Glargine and MK-1293 Pens among Patients with Diabetes and Certified Diabetes Educators Diabetes. 67: 966-P. DOI: 10.2337/db18-966-P  0.066
2015 Witt E, DiBonaventura M. Work Productivity Loss And Activity Impairment Across Nineteen Medical Conditions In A Representative Sample Of Us Adults Value in Health. 18: A176. DOI: 10.1016/J.Jval.2015.03.1018  0.065
2013 Kinoshita Y, Dibonaventura M, Rossi B, Iwamoto K, Wang EC, Briere JB. Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia. Clinical and Experimental Gastroenterology. 6: 51-9. PMID 23717048 DOI: 10.2147/CEG.S39628  0.064
2013 Pisa G, DiBonaventura M. Work Impairment Burden of Anxiety and Depression in Germany Value in Health. 16: A551. DOI: 10.1016/j.jval.2013.08.1424  0.063
2014 Lasch K, Ursos L, Liu S, Mody R, Concialdi K, DiBonaventura M, Leberman J, Dubinsky M. Understanding Attitudes, Perceptions, and Beliefs About Ulcerative Colitis Among Gastroenterologists: Phase 1 Survey Results American Journal of Gastroenterology. 109: S484. DOI: 10.14309/00000434-201410002-01631  0.062
2016 Gerds AT, Binder G, Fliss A, McGuire M, Hawthorne SM, King-Concialdi K, DiBonaventura M. Serum erythropoietin (sEPO) testing and treatment patterns for transfusion-dependent (TD) patients (pts) with myelodysplastic syndromes (MDS). Journal of Clinical Oncology. 34: e18215-e18215. DOI: 10.1200/jco.2016.34.15_suppl.e18215  0.062
2016 DiBonaventura M, Higginbottom K, Meyers A, Morimoto Y, Ilacqua J. Predictors of First Line Treatment Persistence Among Patients with Metastatic Renal Cell Carcinoma in The United States, Western Europe, and Japan Value in Health. 19: A743-A744. DOI: 10.1016/j.jval.2016.09.2270  0.061
2014 Copher R, DiBonaventura M, Basurto E, Faria C, Lorenzo R. Methods To Elicit Patient Preferences: A Case Study In Metastatic Breast Cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A575-6. PMID 27201930 DOI: 10.1016/j.jval.2014.08.1937  0.061
2017 Uemura H, Matsubara N, Kimura G, Yamaguchi A, Ledesma DA, DiBonaventura M, Mohamed AF, Basurto E, McKinnon I, Wang E, Concialdi K, Narimatsu A, Aitoku Y. Erratum to: Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. Bmc Urology. 17: 20. PMID 28351390 DOI: 10.1186/s12894-017-0210-x  0.061
2016 DiBonaventura M, Higginbottom K, Meyers A, Morimoto Y, Ilacqua J. Treatment Pattern Differences Across the United States, Western Europe, and Japan Among Patients with Metastatic Renal Cell Carcinoma Value in Health. 19: A764. DOI: 10.1016/j.jval.2016.09.2382  0.059
2014 Moots R, Strand V, DiBonaventura M, Vasilescu R, Mahgoub E, Tang B. SAT0085 Burden of Rheumatoid Arthritis in Emerging and Developed Countries: Table 1 Annals of the Rheumatic Diseases. 73: 621.1-621. DOI: 10.1136/annrheumdis-2014-eular.4241  0.058
2010 DiBonaventura Md, Panish J, Kenworthy D, Wagner J, Dirani R. The association of well-being, productivity and resource use among community-dwelling patients with schizophrenia using atypical antipsychotics Journal of Pharmaceutical Health Services Research. 1: 181-187. DOI: 10.1111/J.1759-8893.2010.00033.X  0.058
2022 Reich K, Thyssen JP, Blauvelt A, Eyerich K, Soong W, Rice ZP, Hong HC, Katoh N, Valenzuela F, DiBonaventura M, Bratt TA, Zhang F, Clibborn C, Rojo R, Valdez H, et al. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial. Lancet (London, England). 400: 273-282. PMID 35871814 DOI: 10.1016/S0140-6736(22)01199-0  0.056
2014 Tang B, Annunziata K, DiBonaventura M. Burden Of Psoriasis In Developing And Developed Countries Value in Health. 17: A289. DOI: 10.1016/j.jval.2014.03.1682  0.056
2019 Dubinsky M, Bushmakin A, DiBonaventura M, Cappelleri J, Salese L, Maller E, Armuzzi A. P252 Measuring the mediating effects of Mayo score components for tofacitinib on disease-specific quality of life in ulcerative colitis: data from the OCTAVE programme Journal of Crohn's and Colitis. 13: S222-S223. DOI: 10.1093/ecco-jcc/jjy222.376  0.056
2019 Dubinsky M, Bushmakin AG, DiBonaventura Md, Cappelleri JC, Salese L, Maller ES, Armuzzi A. Sa1873 – Measuring the Mediating Effects of Mayo Score Components for Tofacitinib on Disease-Specific Quality of Life in Ulcerative Colitis: Data from the Octave Program Gastroenterology. 156: S-437. DOI: 10.1016/S0016-5085(19)37939-9  0.055
2010 Toghanian S, DiBonaventura M, Järbrink K, Locklear J. PMH16 THE ECONOMIC AND HUMANISTIC BURDEN OF ILLNESS IN GENERALISED ANXIETY DISORDER (GAD): A RETROSPECTIVE DATABASE ANALYSIS IN EUROPE Value in Health. 13: A448. DOI: 10.1016/S1098-3015(11)72893-5  0.054
2016 DiBonaventura M, Pomerantz D, Mondry B. THE REAL-WORLD PAIN EXPERIENCE OF ADULTS WITH RHEUMATOID ARTHRITIS USING A MOBILE SURVEY Value in Health. 19: A236. DOI: 10.1016/j.jval.2016.03.1095  0.053
2021 Kim BS, Silverberg JI, Ständer S, Yosipovitch G, Simpson EL, DiBonaventura M, Kerkmann U, Farooqui SA, Biswas P, Valdez H, Cameron MC. Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies. Dermatitis : Contact, Atopic, Occupational, Drug. PMID 34175862 DOI: 10.1097/DER.0000000000000770  0.051
2016 Yamabe K, Witt E, DiBonaventura M. The Burden of Multiple Sclerosis in Japan Value in Health. 19: A66. DOI: 10.1016/J.Jval.2016.03.243  0.051
2014 DiBonaventura M, Copher R, Basurto E, Faria C, Lorenzo R. The Association Between Non-Adherence and Quality of Life Among Women with Metastatic Breast Cancer Value in Health. 17: A92. DOI: 10.1016/j.jval.2014.03.534  0.05
2013 Denno MS, Gillard PJ, Graham GD, DiBonaventura MD, Goren A, Varon SF, Zorowitz R. Anxiety and depression associated with caregiver burden in caregivers of stroke survivors with spasticity. Archives of Physical Medicine and Rehabilitation. 94: 1731-6. PMID 23548544 DOI: 10.1016/j.apmr.2013.03.014  0.049
2016 Lee L, Kudel I, DiBonaventura M, Schepart A, Kellstein D. Effects of Opioid use with and without Over-The-Counter Analgesics on Economic Outcomes Among Adults with Pain in the United States Value in Health. 19: A594. DOI: 10.1016/j.jval.2016.09.1427  0.049
2014 Kumar M, DiBonaventura M. Literature Review Of Functional, Educational, And Motivational Adherence Interventions Value in Health. 17: A162. DOI: 10.1016/j.jval.2014.03.944  0.049
2012 DiBonaventura M, Yuan Y, Lescrauwaet B, L'Italien G, Liu G, Kamae I, Mauskopf J. PIN47 The Humanistic and Economic Burden of Hepatitis C Across the United States, Europe, and Asia Value in Health. 15: A245-A246. DOI: 10.1016/J.JVAL.2012.03.1323  0.049
2012 Le Pautremat V, Eschwège E, DiBonaventura M, Isherwood G. P116 L’impact de l’obésité sur la santé des patients diabétiques de type 2 en France, en Allemagne et en Grande Bretagne Diabetes & Metabolism. 38: A59. DOI: 10.1016/S1262-3636(12)71218-1  0.048
2018 Rubin DT, Ashaye A, Zhang Y, Fahrbach K, Freitag A, Kayhan C, Lohan C, Cappelleri JC, DiBonaventura M. Efficacy of Tofacitinib and Biologics as Induction and Maintenance Therapy for Moderately-to-Severely Active Ulcerative Colitis: A Systematic Review and Network Meta-Analysis: Presidential Poster Award American Journal of Gastroenterology. 113: S402-S403. DOI: 10.14309/00000434-201810001-00718  0.047
2016 Hopps M, DiBonaventura M, Kudel I, Concialdi K, Sadosky A, Parsons B, Cappelleri J, Hlavacek P, Alexander A, Stacey B, Farrar J, Markman J. (146) Characteristics associated with non-diagnosed neuropathic pain in the United States. The Journal of Pain : Official Journal of the American Pain Society. 17: S12. PMID 28162367 DOI: 10.1016/J.Jpain.2016.01.049  0.047
2013 Gupta S, DiBonaventura M. Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory Value in Health. 16: A597. DOI: 10.1016/J.JVAL.2013.08.1681  0.046
2018 Smith TW, DiBonaventura M, Gruben D, Bargo D, Salese L, Quirk D. Dose Escalation and Treatment Patterns of Advanced Therapies Used to Treat Ulcerative Colitis: A Retrospective Database Analysis in the United States American Journal of Gastroenterology. 113: S353. DOI: 10.14309/00000434-201810001-00622  0.044
2013 DiBonaventura M, Nasonov EL, Vasilescu R, Tang B. AB0765 Burden of rheumatoid arthritis in russia in the real world setting Annals of the Rheumatic Diseases. 72: A1023.1-A1023. DOI: 10.1136/annrheumdis-2013-eular.3087  0.041
2010 Bell C, Stacey B, DiBonaventura M, Martin S. Assessing the relationship between pain intensity and quality of life in subjects with painful diabetic peripheral neuropathy The Journal of Pain. 11: S8. DOI: 10.1016/j.jpain.2010.01.038  0.041
2017 Uemura H, DiBonaventura M, Wang E, Ledesma DA, Concialdi K, Aitoku Y. The treatment patterns of castration-resistant prostate cancer in Japan, including symptomatic skeletal events and associated treatment and healthcare resource use. Expert Review of Pharmacoeconomics & Outcomes Research. PMID 28277852 DOI: 10.1080/14737167.2017.1300530  0.04
2019 Udall M, Kudel I, Cappelleri JC, Sadosky A, King-Concialdi K, Parsons B, Hlavacek P, Hopps M, Salomon PA, DiBonaventura MD, Clark P, Garcia JBS. Epidemiology of physician-diagnosed neuropathic pain in Brazil. Journal of Pain Research. 12: 243-253. PMID 30662280 DOI: 10.2147/JPR.S160504  0.039
2017 Higginbottom K, Dibonaventura M, Penrod J, Yuan Y. MA 01.09 Treatment Patterns in Extensive Disease Small Cell Lung Cancer Across the United States, Europe, and Japan Journal of Thoracic Oncology. 12: S1801-S1802. DOI: 10.1016/J.JTHO.2017.09.448  0.039
2016 DiBonaventura M, Higginbottom K, Meyers A, Ilacqua J, Morimoto Y. Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Western Europe Value in Health. 19: A765. DOI: 10.1016/j.jval.2016.09.2387  0.035
2010 DiBonaventura M, Roy S, Ertl J, Cifaldi M. PMS66 REAL-WORLD TRENDS IN THE DIAGNOSIS AND ASSESSMENT OF RHEUMATOID ARTHRITIS (RA) AMONG RHEUMATOLOGISTS IN THE UNITED STATES Value in Health. 13: A135. DOI: 10.1016/S1098-3015(10)72652-8  0.035
2016 DiBonaventura M, Higginbottom K, Meyers A, Morimoto Y, Ilacqua J. Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Japan Value in Health. 19: A765. DOI: 10.1016/j.jval.2016.09.2388  0.035
2011 Wagner J, Gross H, DiBonaventura M. PGI27 Sleep Disturbance and Quality of Life Among Hepatitis C Infected Individuals Value in Health. 14: A396. DOI: 10.1016/j.jval.2011.08.898  0.034
2010 Bell C, Stacey B, DiBonaventura M, Martin S. Chronological characteristics of painful diabetic peripheral neuropathy: assessing the variation in daily pain intensity over the course of 7 days The Journal of Pain. 11: S6. DOI: 10.1016/j.jpain.2010.01.031  0.031
2013 Moline M, Brown D, Dibonaventura M, Lorenzo R, Shah D, Ben-Joseph R. Treatment patterns among those who experience middle-of-the-night awakening (MOTN) Sleep Medicine. 14: e211. DOI: 10.1016/j.sleep.2013.11.505  0.031
2014 Eichmann F, DiBonaventura M, Schoefer A. Trends in Physical and Occupational Therapy Utilziation in the Us And Western Europe. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A406. PMID 27200986 DOI: 10.1016/j.jval.2014.08.944  0.03
2013 Pignot M, DiBonaventura M, Gupta S. The Effect Of Insulin Pump Therapy On Hba1c Among Those With Type-1 Diabetes Value in Health. 16: A156. DOI: 10.1016/J.JVAL.2013.03.778  0.029
2021 Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, et al. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis. The New England Journal of Medicine. 384: 1101-1112. PMID 33761207 DOI: 10.1056/NEJMoa2019380  0.029
2010 DiBonaventura MD, Erblich J, Sloan RP, Bovbjerg DH. A computerized Stroop task to assess cancer-related cognitive biases. Behavioral Medicine (Washington, D.C.). 36: 37-43. PMID 20497941 DOI: 10.1080/08964280903521321  0.028
2016 DiBonaventura M, Meyers A, Higginbottom K, Morimoto Y, Ilacqua J. Predictors of PD-L1 Testing in Non-Small Cell Lung Cancer Value in Health. 19: A763. DOI: 10.1016/j.jval.2016.09.2378  0.021
2015 Uemura H, DiBonaventura MD, Wang EC, Ledesma D, Concialdi K, Aitoku Y. The Treatment Patterns Of Castration Resistant Prostate Cancer In Japan. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A437. PMID 26532460 DOI: 10.1016/j.jval.2015.09.1061  0.015
Hide low-probability matches.